UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Internuclear ophthalmoparesis

Authors
Teresa C Frohman, PA-C
Elliot M Frohman, MD, PhD
Section Editor
Paul W Brazis, MD
Deputy Editor
Janet L Wilterdink, MD

INTRODUCTION

Internuclear ophthalmoparesis (INO), also commonly referred to as internuclear ophthalmoplegia, is a specific gaze abnormality characterized by impaired horizontal eye movements with weak adduction of the affected eye, and abduction nystagmus of the contralateral eye. It is one of the most localizing brainstem syndromes, resulting from a lesion in the medial longitudinal fasciculus (MLF) in the dorsomedial brainstem tegmentum of either the pons or the midbrain [1].

OCULOMOTOR CIRCUITRY

Foveation or visual targeting with binocular fusion and stereoscopy (depth perception) requires highly synchronous eye movements that place objects of visual interest on the corresponding points of both retinas. This process is dependent upon the precise coordination between cranial nerves III, IV, and VI, and their interneuronal pathways that project through the medial longitudinal fasciculus (MLF) (figure 1).

The paramedian pontine reticular formation (PPRF) is often referred to as the conjugate gaze center for horizontal eye movements. During horizontal eye movement, the PPRF burst cells innervate the abducens nucleus, which contains two distinctive sets of neurons:

Axons of the abducens motor neurons directly innervate the ipsilateral lateral rectus muscle.

Axons of the abducens interneurons cross the midline to become the MLF and subsequently innervate the medial rectus subnucleus of the oculomotor complex (cranial nerve nucleus III). Motor neurons from this subnucleus innervate the medial rectus muscle (ipsilateral to the medial rectus subnucleus and contralateral to the abducens nucleus).

                       
To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Dec 04, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Frohman EM, Zhang H, Kramer PD, et al. MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis. Neurology 2001; 57:762.
  2. Wray SH. Horizontal gaze and syndromes of the pons. In: Eye Movement Disorders in Clinical Practice, Oxford University Press, New York 2014. p.207.
  3. Kim JS. Internuclear ophthalmoplegia as an isolated or predominant symptom of brainstem infarction. Neurology 2004; 62:1491.
  4. Evinger LC, Fuchs AF, Baker R. Bilateral lesions of the medial longitudinal fasciculus in monkeys: effects on the horizontal and vertical components of voluntary and vestibular induced eye movements. Exp Brain Res 1977; 28:1.
  5. Ranalli PJ, Sharpe JA. Vertical vestibulo-ocular reflex, smooth pursuit and eye-head tracking dysfunction in internuclear ophthalmoplegia. Brain 1988; 111 ( Pt 6):1299.
  6. Bolaños I, Lozano D, Cantú C. Internuclear ophthalmoplegia: causes and long-term follow-up in 65 patients. Acta Neurol Scand 2004; 110:161.
  7. Cremer PD, Migliaccio AA, Halmagyi GM, Curthoys IS. Vestibulo-ocular reflex pathways in internuclear ophthalmoplegia. Ann Neurol 1999; 45:529.
  8. Zwergal A, Cnyrim C, Arbusow V, et al. Unilateral INO is associated with ocular tilt reaction in pontomesencephalic lesions: INO plus. Neurology 2008; 71:590.
  9. Sakaie K, Takahashi M, Dimitrov I, et al. Diffusion tensor imaging the medial longitudinal fasciculus in INO: opportunities and challenges. Ann N Y Acad Sci 2011; 1233:307.
  10. Sakaie K, Takahashi M, Sagiyama K, et al. Injury to a specific neural pathway detected by ultra-high-field MRI. Neurology 2014; 82:182.
  11. Mills DA, Frohman TC, Davis SL, et al. Break in binocular fusion during head turning in MS patients with INO. Neurology 2008; 71:458.
  12. Frohman EM, Frohman TC, Zee DS, et al. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol 2005; 4:111.
  13. Zee DS, Hain TC, Carl JR. Abduction nystagmus in internuclear ophthalmoplegia. Ann Neurol 1987; 21:383.
  14. Baloh RW, Yee RD, Honrubia V. Internuclear ophthalmoplegia. I. Saccades and dissociated nystagmus. Arch Neurol 1978; 35:484.
  15. Flipse JP, Straathof CS, Van der Steen J, et al. Binocular saccadic eye movements in multiple sclerosis. J Neurol Sci 1997; 148:53.
  16. Zee DS. Internuclear ophthalmoplegia: pathophysiology and diagnosis. Baillieres Clin Neurol 1992; 1:455.
  17. Bronstein AM, Rudge P, Gresty MA, et al. Abnormalities of horizontal gaze. Clinical, oculographic and magnetic resonance imaging findings. II. Gaze palsy and internuclear ophthalmoplegia. J Neurol Neurosurg Psychiatry 1990; 53:200.
  18. Keane JR. Internuclear ophthalmoplegia - a reply. Arch Neurol 2006; 63:626.
  19. Jung DS, Park KP. Posttraumatic bilateral internuclear ophthalmoplegia with exotropia. Arch Neurol 2004; 61:429.
  20. Eggenberger E. Eight-and-a-half syndrome: one-and-a-half syndrome plus cranial nerve VII palsy. J Neuroophthalmol 1998; 18:114.
  21. Kakar P, Brown Z, Banerjee S. Eight-and-a-half syndrome: an unusual presentation of brainstem infarction. QJM 2013; 106:273.
  22. Marquart C, Strauss C, Alfieri A. Eight-and-a-half syndrome combined with an ipsilateral vertical gaze palsy: a pathophysiological explanation. Clin Neurol Neurosurg 2013; 115:767.
  23. Sampath Kumar NS, Raju CG, Kiran PR, et al. Eight-and-a-half syndrome: a rare presentation of pontine infarction. J Stroke Cerebrovasc Dis 2014; 23:e389.
  24. Bocos-Portillo J, Ruiz Ojeda J, Gomez-Beldarrain M, et al. Eight-and-a-Half Syndrome. JAMA Neurol 2015; 72:830.
  25. Xie WJ, Yu HQ, Wang YH, et al. A case report of eight and a half syndrome. Neurol Sci 2016; 37:821.
  26. Kong WY, Tan YQ, Sia CH, et al. Adding up cranial nerves to localize the lesion: eight-and-a-half syndrome. QJM 2016; 109:627.
  27. Keane JR. Internuclear ophthalmoplegia: unusual causes in 114 of 410 patients. Arch Neurol 2005; 62:714.
  28. Müri RM, Meienberg O. The clinical spectrum of internuclear ophthalmoplegia in multiple sclerosis. Arch Neurol 1985; 42:851.
  29. Meienberg O, Müri R, Rabineau PA. Clinical and oculographic examinations of saccadic eye movements in the diagnosis of multiple sclerosis. Arch Neurol 1986; 43:438.
  30. Frohman EM, Frohman TC, O'Suilleabhain P, et al. Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score. J Neurol Neurosurg Psychiatry 2002; 73:51.
  31. Frohman TC, Davis SL, Frohman EM. Modeling the mechanisms of Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis. Ann N Y Acad Sci 2011; 1233:313.
  32. Frohman TC, Davis SL, Beh S, et al. Uhthoff's phenomena in MS--clinical features and pathophysiology. Nat Rev Neurol 2013; 9:535.
  33. Davis SL, Frohman TC, Crandall CG, et al. Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis. Neurology 2008; 70:1098.
  34. Eggenberger E, Golnik K, Lee A, et al. Prognosis of ischemic internuclear ophthalmoplegia. Ophthalmology 2002; 109:1676.
  35. Gray OM, Forbes RB, Morrow JI. Primary isolated brainstem injury producing internuclear ophthalmoplegia. Br J Neurosurg 2001; 15:432.
  36. Constantoyannis C, Tzortzidis F, Papadakis N. Internuclear ophthalmoplegia following minor head injury: a case report. Br J Neurosurg 1998; 12:377.
  37. Matsumoto H, Ohminami S, Goto J, Tsuji S. Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome. Arch Neurol 2008; 65:827.
  38. Flint AC, Williams O. Bilateral internuclear ophthalmoplegia in progressive supranuclear palsy with an overriding oculocephalic maneuver. Mov Disord 2005; 20:1069.
  39. al-Din SN, Anderson M, Eeg-Olofsson O, Trontelj JV. Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review. Acta Neurol Scand 1994; 89:157.
  40. Davis TL, Lavin PJ. Pseudo one-and-a-half syndrome with ocular myasthenia. Neurology 1989; 39:1553.
  41. Korkmaz A, Topaloglu H, Kansu T. Wall eyed bilateral internuclear ophthalmoplegia in chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 2002; 9:691.
  42. Lifshitz M, Gavrilov V, Sofer S. Signs and symptoms of carbamazepine overdose in young children. Pediatr Emerg Care 2000; 16:26.
  43. Solingen LD, Baloh RW, Myers L, Ellison G. Subclinical eye movement disorders in patients with multiple sclerosis. Neurology 1977; 27:614.
  44. Frohman TC, Frohman EM, O'Suilleabhain P, et al. Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography. Neurology 2003; 61:848.
  45. SMITH JL, DAVID NJ. INTERNUCLEAR OPHTHALMOPLEGIA. TWO NEW CLINICAL SIGNS. Neurology 1964; 14:307.
  46. Atlas SW, Grossman RI, Savino PJ, et al. Internuclear ophthalmoplegia: MR-anatomic correlation. AJNR Am J Neuroradiol 1987; 8:243.
  47. Serra A, Skelly MM, Jacobs JB, et al. Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine. Neurology 2014; 83:192.
  48. Murthy R, Dawson E, Khan S, et al. Botulinum toxin in the management of internuclear ophthalmoplegia. J AAPOS 2007; 11:456.
  49. Safarpour Y, Mousavi T, Jabbari B. Botulinum Toxin Treatment in Multiple Sclerosis-a Review. Curr Treat Options Neurol 2017; 19:33.